Kalyanashis Jana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kalyanashis Jana has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Bishwajit Ganguly
Computation and Simulation Unit, CSIR-Central Salt & Marine Chemicals Research Institute, Bhavnagar, Gujarat 364002, India
13 shared publications - Ulrich Kleinekathöfer
Constructor University
4 shared publications Shibaji Ghosh
Computational and Simulation Unit (Marine Elements and Marine Environment Division and Centralized Instrument Facility), CSIR-Central Salt & Marine Chemicals Research Institute, Bhavnagar-364002, Gujarat, India
3 shared publications- Tusar Bandyopadhyay
Theoretical Chemistry Section, Chemistry Division, Bhabha Atomic Research Centre, Mumbai, India
3 shared publications - Kozhinjampara R. Mahendran
Membrane Biology Laboratory, Transdisciplinary Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India
2 shared publications Nazar Hussain
Academy of Scientific and Innovative Research
2 shared publications
Latest Publications
- Open Access
- 28 August 2026
- Published by Springer Nature in Nature Nanotechnology
- Vol. 21 (10) , 1467-1478
A self-assembled peptide forms α-helical nanopores for ultrasensitive biomarker profiling
- 28 August 2026
- Published by Springer Nature in Nature Nanotechnology
- Vol. 21 (10) , 1467-1478
Open AccessA self-assembled peptide forms α-helical nanopores for ultrasensitive biomarker profiling
- 12 December 2025
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 28 (2) , 1281-1292
Unraveling the stereoisomeric toxicity of V-series nerve agent VX on human acetylcholinesterase: a well-tempered metadynamics study
Highly toxic organophosphorus nerve agents exert their severe toxicity by inhibiting AChE irreversibly through the phosphonylation of Ser203 within the catalytic triad. The inhibition of AChE varies with stereoisomeric nerve agents. The inhibition mechanism of AChE by stereoselective nerve agents remains elusive. This study explores the mechanism of inhibition of hAChE by stereoselective nerve agents using well-tempered metadynamics (WT-MtD) simulations. The stereoisomeric nerve agent VX (in PS and PR forms) has been examined because it is known from the literature that the PS form of VX inhibits human AChE faster than the PR form. The 1D free energy surface profiles from the WT-MtD simulations reveal that the PS_VX nerve agent binds more strongly (∼4.0 kcal mol−1) with hAChE than the PR_VX nerve agent. The WT-MtD simulation results showed that the catalytic triad residues Ser203, His447, and Glu334 play an important role in governing the inhibition process of hAChE by stereoisomeric VX nerve agents. The catalytic triad Ser203, His447, and Glu334 of hAChE aligns in a very similar fashion to that observed for the hydrolysis of acetylcholine (ACh) by PS_VX. The aligned triad residues assist in generating the nucleophilic center at Ser203 for attack on the electrophilic phosphorus center of PS_VX more effectively than PR_VX. The WT-MtD snapshots taken from basin I for both stereoisomers of the nerve agents, used for superimposition onto the apo crystal structure of hAChE, show that the catalytic triad of PR_VX bound hAChE is not aligned with the catalytic triad of the crystal structure. The role of water molecules in the slower inhibition of PR_VX has also been investigated.
- 12 December 2025
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 28 (2) , 1281-1292
Unraveling the stereoisomeric toxicity of V-series nerve agent VX on human acetylcholinesterase: a well-tempered metadynamics study
Highly toxic organophosphorus nerve agents exert their severe toxicity by inhibiting AChE irreversibly through the phosphonylation of Ser203 within the catalytic triad. The inhibition of AChE varies with stereoisomeric nerve agents. The inhibition mechanism of AChE by stereoselective nerve agents remains elusive. This study explores the mechanism of inhibition of hAChE by stereoselective nerve agents using well-tempered metadynamics (WT-MtD) simulations. The stereoisomeric nerve agent VX (in PS and PR forms) has been examined because it is known from the literature that the PS form of VX inhibits human AChE faster than the PR form. The 1D free energy surface profiles from the WT-MtD simulations reveal that the PS_VX nerve agent binds more strongly (∼4.0 kcal mol−1) with hAChE than the PR_VX nerve agent. The WT-MtD simulation results showed that the catalytic triad residues Ser203, His447, and Glu334 play an important role in governing the inhibition process of hAChE by stereoisomeric VX nerve agents. The catalytic triad Ser203, His447, and Glu334 of hAChE aligns in a very similar fashion to that observed for the hydrolysis of acetylcholine (ACh) by PS_VX. The aligned triad residues assist in generating the nucleophilic center at Ser203 for attack on the electrophilic phosphorus center of PS_VX more effectively than PR_VX. The WT-MtD snapshots taken from basin I for both stereoisomers of the nerve agents, used for superimposition onto the apo crystal structure of hAChE, show that the catalytic triad of PR_VX bound hAChE is not aligned with the catalytic triad of the crystal structure. The role of water molecules in the slower inhibition of PR_VX has also been investigated.
- Open Access
- 2 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Fabrication of cytotoxic mirror image nanopores
Synthetic nanopores composed of mirror-image peptides have been reported, but not fully functional mirror-image pores. Here, we construct a monodisperse mirror-image nanopore, DpPorA and characterise its functional properties. Importantly, we alter the charge pattern and assemble a superior mirror-image pore with enhanced conductance and selectivity under different salt conditions. This pore is used for single-molecule sensing of structurally divergent biomolecules, including peptides, PEGylated polypeptides, full-length alpha-synuclein protein and cyclic sugars. Molecular dynamics simulations confirm these DpPorA are exact mirror-images of LpPorA, further revealing their structurally stable conformation. Fluorescence imaging of giant vesicles reconstituted with mirror-image peptides reveals the formation of large flexible pores facilitating size-dependent molecular transport. To explore biomedical applications, the differential cytotoxic effect of mirror-image peptides and their fluorescently tagged forms on cancer cells demonstrates a significant effect on membrane disruption and cell viability, as opposed to no effect on normal cells. We emphasize that this class of mirror-image pores can advance the development of molecular sensors and therapeutics.
- 2 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Open AccessFabrication of cytotoxic mirror image nanopores
Synthetic nanopores composed of mirror-image peptides have been reported, but not fully functional mirror-image pores. Here, we construct a monodisperse mirror-image nanopore, DpPorA and characterise its functional properties. Importantly, we alter the charge pattern and assemble a superior mirror-image pore with enhanced conductance and selectivity under different salt conditions. This pore is used for single-molecule sensing of structurally divergent biomolecules, including peptides, PEGylated polypeptides, full-length alpha-synuclein protein and cyclic sugars. Molecular dynamics simulations confirm these DpPorA are exact mirror-images of LpPorA, further revealing their structurally stable conformation. Fluorescence imaging of giant vesicles reconstituted with mirror-image peptides reveals the formation of large flexible pores facilitating size-dependent molecular transport. To explore biomedical applications, the differential cytotoxic effect of mirror-image peptides and their fluorescently tagged forms on cancer cells demonstrates a significant effect on membrane disruption and cell viability, as opposed to no effect on normal cells. We emphasize that this class of mirror-image pores can advance the development of molecular sensors and therapeutics.
- 28 March 2023
- Published by Elsevier in Biophysical Journal
- Vol. 122 (14) , 2996-3007
Fast prediction of antibiotic permeability through membrane channels using Brownian dynamics
- 28 March 2023
- Published by Elsevier in Biophysical Journal
- Vol. 122 (14) , 2996-3007
Fast prediction of antibiotic permeability through membrane channels using Brownian dynamics
- Open Access
BtuB TonB-dependent transporters and BtuG surface lipoproteins form stable complexes for vitamin B 12 uptake in gut Bacteroides
Vitamin B 12 (cobalamin) is the most complex vitamin and essential for many human gut microbes. However, cobalamin is synthesised only by a limited number of bacteria, making many gut microbes dependent on scavenging to meet their cobalamin requirements. Since bacterial densities in the gut are extremely high, competition for cobalamin is severe, making it a keystone micronutrient that shapes human gut microbial communities. Contrasting with Enterobacteria like Escherichia coli which only have one outer membrane (OM) transporter dedicated to B 12 uptake (BtuB), members of the dominant genus Bacteroides often encode several vitamin B 12 OM transporters together with a conserved array of surface-exposed B 12 -binding lipoproteins. Here we show, via X-ray crystallography, cryogenic electron microscopy (cryoEM) and molecular dynamics (MD) simulations, that the BtuB1 and BtuB2 transporters from the prominent human gut bacterium Bacteroides thetaiotaomicron form stable complexes with the surface-exposed lipoproteins BtuG1 and BtuG2. The lipoproteins cap the external surface of their cognate BtuB transporter and, when open, capture B 12 via electrostatic attraction. After B 12 capture, the BtuG lid closes, with concomitant transfer of the vitamin to the BtuB transporter and subsequent transport. We propose that TonB-dependent, lipoprotein-assisted small molecule uptake is a general feature of Bacteroides spp . that is important for the success of this genus in colonising the human gut.
Open AccessBtuB TonB-dependent transporters and BtuG surface lipoproteins form stable complexes for vitamin B 12 uptake in gut Bacteroides
Vitamin B 12 (cobalamin) is the most complex vitamin and essential for many human gut microbes. However, cobalamin is synthesised only by a limited number of bacteria, making many gut microbes dependent on scavenging to meet their cobalamin requirements. Since bacterial densities in the gut are extremely high, competition for cobalamin is severe, making it a keystone micronutrient that shapes human gut microbial communities. Contrasting with Enterobacteria like Escherichia coli which only have one outer membrane (OM) transporter dedicated to B 12 uptake (BtuB), members of the dominant genus Bacteroides often encode several vitamin B 12 OM transporters together with a conserved array of surface-exposed B 12 -binding lipoproteins. Here we show, via X-ray crystallography, cryogenic electron microscopy (cryoEM) and molecular dynamics (MD) simulations, that the BtuB1 and BtuB2 transporters from the prominent human gut bacterium Bacteroides thetaiotaomicron form stable complexes with the surface-exposed lipoproteins BtuG1 and BtuG2. The lipoproteins cap the external surface of their cognate BtuB transporter and, when open, capture B 12 via electrostatic attraction. After B 12 capture, the BtuG lid closes, with concomitant transfer of the vitamin to the BtuB transporter and subsequent transport. We propose that TonB-dependent, lipoprotein-assisted small molecule uptake is a general feature of Bacteroides spp . that is important for the success of this genus in colonising the human gut.
- 1 July 2021
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 19 (28) , 6353-6367
The mechanism of conversion of substituted glycals to chiral acenes via Diels–Alder reaction: a computational study
Synthesis of linearly fused aromatic systems using a glycal-based diene with an aryne is a long-standing topic of interest in glycal chemistry. We have examined the mechanistic pathways for the transformation of substituted glycals to chiral fused aromatic cores via Diels–Alder (DA) reaction using the SMDACN-M06-2X/6-31G(d) level of theory. The DA reactions of E (1a) and Z (1a′) forms of C-2 alkenyl glycal and an aryl glycal (1b) as a diene were examined with a benzyne intermediate generated as a dienophile. The computational results reveal that 1a and 1b can only be transformed into the fused aromatic cores by the base-catalyzed reaction because a [1,5] sigmatropic hydrogen shift is not feasible. The activation free energy barrier for the base-catalyzed proton abstraction process is 4.2 kcal mol−1 and there is almost no barrier for stereoisomeric 1a DA-complexes. The activation free energy barrier values for stereoisomeric 1b DA-complexes for the base-catalyzed proton abstraction process are 10.8 and 12.4 kcal mol−1. The appropriate orientation of glycal-ring-oxygen and hydrogen at the 5th position of Z (1a′) forms of C-2 alkenyl glycal facilitates the [1,5] sigmatropic hydrogen shift; however, the base-catalyzed reaction is energetically more favored than the former case. The rate-determining step for 1a and 1a′ is the ring-opening step (18.2 and 19.5 kcal mol−1 for the S-stereoisomer), whereas the DA adduct formation step is the rate-determining step for 1b (16.1 kcal mol−1 for the S-stereoisomer). The structural analysis reveals the formation of the preferred S-stereoisomer over the R-stereoisomer with the respective dienes.
- 1 July 2021
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 19 (28) , 6353-6367
The mechanism of conversion of substituted glycals to chiral acenes via Diels–Alder reaction: a computational study
Synthesis of linearly fused aromatic systems using a glycal-based diene with an aryne is a long-standing topic of interest in glycal chemistry. We have examined the mechanistic pathways for the transformation of substituted glycals to chiral fused aromatic cores via Diels–Alder (DA) reaction using the SMDACN-M06-2X/6-31G(d) level of theory. The DA reactions of E (1a) and Z (1a′) forms of C-2 alkenyl glycal and an aryl glycal (1b) as a diene were examined with a benzyne intermediate generated as a dienophile. The computational results reveal that 1a and 1b can only be transformed into the fused aromatic cores by the base-catalyzed reaction because a [1,5] sigmatropic hydrogen shift is not feasible. The activation free energy barrier for the base-catalyzed proton abstraction process is 4.2 kcal mol−1 and there is almost no barrier for stereoisomeric 1a DA-complexes. The activation free energy barrier values for stereoisomeric 1b DA-complexes for the base-catalyzed proton abstraction process are 10.8 and 12.4 kcal mol−1. The appropriate orientation of glycal-ring-oxygen and hydrogen at the 5th position of Z (1a′) forms of C-2 alkenyl glycal facilitates the [1,5] sigmatropic hydrogen shift; however, the base-catalyzed reaction is energetically more favored than the former case. The rate-determining step for 1a and 1a′ is the ring-opening step (18.2 and 19.5 kcal mol−1 for the S-stereoisomer), whereas the DA adduct formation step is the rate-determining step for 1b (16.1 kcal mol−1 for the S-stereoisomer). The structural analysis reveals the formation of the preferred S-stereoisomer over the R-stereoisomer with the respective dienes.
- Open Access
Force-Field Benchmarking by Alternatives: A Systematic Study of Ten Small α- and β-Proteins
Predicting protein structure from sequence is a central challenge of biochemistry, yet different force fields feature distinct structural biases that are hard to quantify, preventing clear assessment of results. Since structural transitions occur on milliseconds to seconds, sampling is out of reach in almost all routine studies, we inherently rely on local sampled structures, and benchmarks have emphasized the ability to reproduce these local structures. Here we approach the force field bias problem in a different way, via alternatives , by revisiting the old question: How unique is the sequence-structure relationship when studied computationally? To circumvent the sampling problem, the system-bias (specific structure choices affect apparent force field structural preference) and the complexity of tertiary structure, we studied ten small α- and β-proteins (20-35 amino acids) with one helix or sheet. For each of the ten sequences, we then designed alternative β- or α-structures and subjected all 20 proteins to molecular dynamics simulations. We apply this “alternative structure” benchmark to five of the best modern force fields: Amber ff99SB-ILDN, Amber ff99SB*-ILDN, CHARMM22*, CHARMM36, and GROMOS54A8. Surprisingly, we find that all sequences with reported β-structures also feature stable native-like α-structures with all five force fields. In contrast, only the alternative β-1T5Q and to some extent β-1CQ0 and β-1V1D resembled native β-proteins. With full phase space sampling being impossible in almost all cases, our benchmark by alternatives, which samples another local part of phase space in direct comparison, is a useful complement to millisecond benchmarks when these become more common.
Open AccessForce-Field Benchmarking by Alternatives: A Systematic Study of Ten Small α- and β-Proteins
Predicting protein structure from sequence is a central challenge of biochemistry, yet different force fields feature distinct structural biases that are hard to quantify, preventing clear assessment of results. Since structural transitions occur on milliseconds to seconds, sampling is out of reach in almost all routine studies, we inherently rely on local sampled structures, and benchmarks have emphasized the ability to reproduce these local structures. Here we approach the force field bias problem in a different way, via alternatives , by revisiting the old question: How unique is the sequence-structure relationship when studied computationally? To circumvent the sampling problem, the system-bias (specific structure choices affect apparent force field structural preference) and the complexity of tertiary structure, we studied ten small α- and β-proteins (20-35 amino acids) with one helix or sheet. For each of the ten sequences, we then designed alternative β- or α-structures and subjected all 20 proteins to molecular dynamics simulations. We apply this “alternative structure” benchmark to five of the best modern force fields: Amber ff99SB-ILDN, Amber ff99SB*-ILDN, CHARMM22*, CHARMM36, and GROMOS54A8. Surprisingly, we find that all sequences with reported β-structures also feature stable native-like α-structures with all five force fields. In contrast, only the alternative β-1T5Q and to some extent β-1CQ0 and β-1V1D resembled native β-proteins. With full phase space sampling being impossible in almost all cases, our benchmark by alternatives, which samples another local part of phase space in direct comparison, is a useful complement to millisecond benchmarks when these become more common.
- 12 October 2019
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 38 (15) , 4635-4643
Quantum chemical and well-tempered metadynamics study to design adenine analogs for orthogonal Preq1 riboswitch
Riboswitches are present in all three domains of life and control gene expression in response to specific metabolites and are known as cognate ligands of such riboswitches. We explored the binding affinity of reported and designed ligands toward wild’type riboswitch and C19U mutant (M1). We performed DFT study with guanine analog ligands PreQ0, and PreQ1, whereas adenine analog DPQ0, and DAP ligand molecules were considered to explore the binding affinity with PreQ1 riboswitch and its mutant. Therefore, we designed adenine analog L1 and L2 ligand molecules and their binding affinity with orthogonal riboswitch M1. The DFT results suggested that the adenine analog L1 and L2 having a greater binding affinity, which can express and repress gene expression compared to that analogous DPQ0. Well’tempered metadynamics simulations for PreQ1’wild riboswitch, L1’M1, and L2’M1 revealed the folding and unfolding of the riboswitch upon ligand binding process. The free energy surface of the unbinding transition of PreQ1, L1, and L2 showed that the designed ligands enjoy longer interactions with the aptamer domain. The radius of gyration analysis demonstrated the unfolding process of the wild-type, and M1 orthogonal riboswitch during the ligand unbinding processes manifest their effect in the geometrical changes in riboswitch.
- 12 October 2019
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 38 (15) , 4635-4643
Quantum chemical and well-tempered metadynamics study to design adenine analogs for orthogonal Preq1 riboswitch
Riboswitches are present in all three domains of life and control gene expression in response to specific metabolites and are known as cognate ligands of such riboswitches. We explored the binding affinity of reported and designed ligands toward wild’type riboswitch and C19U mutant (M1). We performed DFT study with guanine analog ligands PreQ0, and PreQ1, whereas adenine analog DPQ0, and DAP ligand molecules were considered to explore the binding affinity with PreQ1 riboswitch and its mutant. Therefore, we designed adenine analog L1 and L2 ligand molecules and their binding affinity with orthogonal riboswitch M1. The DFT results suggested that the adenine analog L1 and L2 having a greater binding affinity, which can express and repress gene expression compared to that analogous DPQ0. Well’tempered metadynamics simulations for PreQ1’wild riboswitch, L1’M1, and L2’M1 revealed the folding and unfolding of the riboswitch upon ligand binding process. The free energy surface of the unbinding transition of PreQ1, L1, and L2 showed that the designed ligands enjoy longer interactions with the aptamer domain. The radius of gyration analysis demonstrated the unfolding process of the wild-type, and M1 orthogonal riboswitch during the ligand unbinding processes manifest their effect in the geometrical changes in riboswitch.
- 1 September 2019
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 38 (13) , 3856-3866
Structural insights into the interactions of flavin mononucleotide (FMN) and riboflavin with FMN riboswitch: a molecular dynamics simulation study
Antibiotics resistance is becoming a serious problem associated with fatalities and suffering patients. New antibiotics that can target the broader spectrum of cellular processes are warranted. One of the recent approaches in this regard is to target the special type of RNA riboswitches in bacteria. In this report, we have explored the mechanistic pathways of ligand-dependent conformational changes of Flavin mononucleotide (FMN) riboswitch using molecular dynamics simulation studies. Cognate ligands FMN and riboflavin (RBF) have shown very different behavior with FMN riboswitch in terms of their role in the gene regulation process. These two ligands have similar scaffold, except the terminal phosphate group in FMN ligand. The molecular dynamics simulations reveal that the binding of FMN ligand with the riboswitch does not lead to global folding of structure, rather local changes in riboswitch structure. The binding free energy calculated with Molecular Mechanics Poisson-Boltzmann Surface Area (MMPBSA) method suggests the stronger binding of FMN than RBF to the riboswitch and electrostatic energy contributes chiefly to stabilize the complex. Further, the hydrogen bonding analysis identified the key binding site residues G11, G32, G62 of the riboswitch with FMN and RBF. The critical role of the phosphate group in the FMN ligand for binding with the active site of a riboswitch is also borne out in this study. These results unravel the importance of functional groups in natural ligands on designing newer ligands for FMN riboswitch as new antibiotics in the future.
- 1 September 2019
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 38 (13) , 3856-3866
Structural insights into the interactions of flavin mononucleotide (FMN) and riboflavin with FMN riboswitch: a molecular dynamics simulation study
Antibiotics resistance is becoming a serious problem associated with fatalities and suffering patients. New antibiotics that can target the broader spectrum of cellular processes are warranted. One of the recent approaches in this regard is to target the special type of RNA riboswitches in bacteria. In this report, we have explored the mechanistic pathways of ligand-dependent conformational changes of Flavin mononucleotide (FMN) riboswitch using molecular dynamics simulation studies. Cognate ligands FMN and riboflavin (RBF) have shown very different behavior with FMN riboswitch in terms of their role in the gene regulation process. These two ligands have similar scaffold, except the terminal phosphate group in FMN ligand. The molecular dynamics simulations reveal that the binding of FMN ligand with the riboswitch does not lead to global folding of structure, rather local changes in riboswitch structure. The binding free energy calculated with Molecular Mechanics Poisson-Boltzmann Surface Area (MMPBSA) method suggests the stronger binding of FMN than RBF to the riboswitch and electrostatic energy contributes chiefly to stabilize the complex. Further, the hydrogen bonding analysis identified the key binding site residues G11, G32, G62 of the riboswitch with FMN and RBF. The critical role of the phosphate group in the FMN ligand for binding with the active site of a riboswitch is also borne out in this study. These results unravel the importance of functional groups in natural ligands on designing newer ligands for FMN riboswitch as new antibiotics in the future.
- 21 May 2019
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 21 (25) , 13578-13589
Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study
Donepezil, an acetylcholinesterase inhibitor, is an approved drug for the symptomatic treatment of Alzheimer's disease (AD). The mechanistic pathway for the inhibition mechanism of acetylcholinesterase (AChE) by donepezil is not well explored. We report for the first time, the inhibition mechanism of AChE by the donepezil drug molecule for the hydrolysis of acetylcholine (ACh) with docking and well-tempered metadynamics (WTMtD) simulations with a human acetylcholinesterase (hAChE) crystal structure (4EY7). This study explored the orientation of the donepezil drug molecule inside the gorge of AChE. The 1D free energy surface obtained from WTMtD simulation studies reveals that the orientation of donepezil in the crystal donepezil (−87.25 kJ mol−1) is energetically more favored than the other orientation of donepezil (−74.74 kJ mol−1) for inhibition of AChE. The free energy landscape computation for the two sets of CVs further corroborates the 1D free energy surface. The WTMtD simulation performed with the crystal structure of donepezil bound hAChE gives the conformation of donepezil at Basin-I as similar to the conformation of donepezil observed in the crystal structure (4EY7). The WTMtD simulations further reveal that the bridged water molecules are more ordered near the catalytic triad of AChE to deter the nucleophilicity of Ser203 through intermolecular hydrogen bonding when donepezil approaches near to the active site gorge of AChE. The presence of donepezil near the active site of AChE can inhibit its approach for ACh hydrolysis; this is revealed through the docking study, where the drug molecule inside the active gorge of hAChE restricts the approach of ACh to Ser203 for the hydrolysis process.
- 21 May 2019
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 21 (25) , 13578-13589
Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study
Donepezil, an acetylcholinesterase inhibitor, is an approved drug for the symptomatic treatment of Alzheimer's disease (AD). The mechanistic pathway for the inhibition mechanism of acetylcholinesterase (AChE) by donepezil is not well explored. We report for the first time, the inhibition mechanism of AChE by the donepezil drug molecule for the hydrolysis of acetylcholine (ACh) with docking and well-tempered metadynamics (WTMtD) simulations with a human acetylcholinesterase (hAChE) crystal structure (4EY7). This study explored the orientation of the donepezil drug molecule inside the gorge of AChE. The 1D free energy surface obtained from WTMtD simulation studies reveals that the orientation of donepezil in the crystal donepezil (−87.25 kJ mol−1) is energetically more favored than the other orientation of donepezil (−74.74 kJ mol−1) for inhibition of AChE. The free energy landscape computation for the two sets of CVs further corroborates the 1D free energy surface. The WTMtD simulation performed with the crystal structure of donepezil bound hAChE gives the conformation of donepezil at Basin-I as similar to the conformation of donepezil observed in the crystal structure (4EY7). The WTMtD simulations further reveal that the bridged water molecules are more ordered near the catalytic triad of AChE to deter the nucleophilicity of Ser203 through intermolecular hydrogen bonding when donepezil approaches near to the active site gorge of AChE. The presence of donepezil near the active site of AChE can inhibit its approach for ACh hydrolysis; this is revealed through the docking study, where the drug molecule inside the active gorge of hAChE restricts the approach of ACh to Ser203 for the hydrolysis process.